Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Alma, a Sisram Medical Company, Launches RESHAPE, a Hybrid Body and Face Contouring Platform Featuring the 'Power Couple' of Beauty Treatments Technologies: Ultrasound and Radio Frequency



HONG KONG, November 14, 2018 /PRNewswire/ --

Alma, one of the top five global leaders of energy-based medical and aesthetic solutions, today announced the launch of RESHAPE, the new body and face contouring platform for beauticians at the Cosmoprof Asia tradeshow in Hong Kong.

Based on Alma's gold-standard medical device solutions, and incorporating the company's cutting-edge technology, RESHAPE is a novel hybrid platform that combines two highly effective energy sources - ultrasound and radio frequency - into one synergic solution for fat reduction, skin tightening, and facial anti-aging treatments.

RESHAPE, the latest addition to Alma Beauty product line, offers tailored treatments to meet the needs of different patients, with a choice of three types of applicators:

"We are excited to share our Medical Aesthetics grade technologies with beauty practitioners, enabling more consumers around the world to enjoy safe and effective beauty treatments," said Lior Dayan, Alma's CEO.

About Alma 

Alma is a global innovator of Laser, Light-based, Radiofrequency, Plasma and Ultrasound solutions for the aesthetic and surgical markets. We enable practitioners to offer safe and effective procedures while allowing patients to benefit from state-of-the-art, clinically proven technologies and treatments.

https://www.almalasers.com

For media inquiries, please contact:

ICR Inc.
Edmond Lococo
Tel: +86(10)6583-7510
E-mail: Edmond.lococo@icrinc.com


These press releases may also interest you

at 03:00
FRANKLIN, Wis., Dec. 13, 2018 /PRNewswire-PRWeb/ -- Microbial Discovery Group LLC (MDG) has expanded their HACCP scope which now includes food (human) ingredient. This has been part of their strategic plan and an important milestone in increasing...

at 03:00
PEKIN, Ill., Dec. 13, 2018 /PRNewswire-PRWeb/ -- It is not uncommon for individuals with eating disorders to have strong, aversive reactions to situations that occur in everyday life. According to the novel research of two eating disorders treatment...

at 02:00
Sosei Group Corporation ("the Company"; TSE: 4565), announces that the first healthy subject has been dosed with a novel small molecule HTL0014242 in a Phase I clinical study, marking the start of a new in-house clinical program targeting psychiatric...

at 02:00
The CPhI & P-MEC China 2019 organized by UBM EMEA and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) and co-organized by Shanghai UBM Sinoexpo International Exhibition Co., Ltd. will be held at Shanghai New...

at 02:00
GRAND RAPIDS, Mich., Dec. 13, 2018 /PRNewswire-PRWeb/ -- Candi Hamilton has been named Executive Director for central and southern Michigan Blue Sky Vision practices. Hamilton brings over 22 years of eye care experience to the company. "We are...

at 01:08
Orexo AB (publ.), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces that the Company will regain the rights to Zubsolv (buprenorphine and naloxone sublingual tablet) for the treatment of...




News published on 14 november 2018 at 04:00 and distributed by: